NCT03941769 2024-10-17
2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II
M.D. Anderson Cancer Center
Phase 1/2 Completed
Clinical Trials
8 trialsNCT03513952 2024-07-26
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT04426201 2024-04-11
ILIAD-7-US-O
Revimmune
Phase 2 Terminated
NCT03929107 2019-04-26
Interleukin-7 and Chemokine (C-C Motif) Ligand 19-expressing CD19-CAR-T for Refractory/Relapsed B Cell Lymphoma.
First Affiliated Hospital of Zhejiang University
Phase 2 Unknown
NCT00091338 2015-04-30
Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT01368107 2015-02-09
Study Evaluating Impact of IL-7 on CD4 Lymphopenia, Risks of Severe Haematological Toxicity and Tumor Progression in Metastatic Breast Cancer Patients
Centre Leon Berard
Phase 2 Completed
NCT00492440 2012-10-18
Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer
Cytheris SA
Phase 1 Terminated
NCT00062049 2012-03-08
Interleukin-7 in Treating Patients With Refractory Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed